Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries.

Benzarti S, Daskalakis M, Feller A, Bacher VU, Schnegg-Kaufmann A, Rüfer A, Holbro A, Schmidt A, Benz R, Solenthaler M, Stussi G, Arndt V, Bonadies N; NICER Working Group.

Cancer Epidemiol. 2019 Jan 25;59:51-57. doi: 10.1016/j.canep.2019.01.003. [Epub ahead of print]

PMID:
30690330
2.

Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression.

Junge A, Bacher U, Mueller BU, Keller P, Solenthaler M, Pabst T.

Hematol Oncol. 2018 Jun 3. doi: 10.1002/hon.2516. [Epub ahead of print]

PMID:
29862539
3.

Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias.

Fernandez P, Solenthaler M, Spertini O, Quarroz S, Rovo A, Lovey PY, Leoncini L, Ruault-Jungblut S, D'Asaro M, Schaad O, Docquier M, Descombes P, Matthes T; Swiss Cytometry Society.

PLoS One. 2012;7(11):e49010. doi: 10.1371/journal.pone.0049010. Epub 2012 Nov 9.

4.

Pyrazinamide-induced sideroblastic anemia.

Colucci G, Silzle T, Solenthaler M.

Am J Hematol. 2012 Mar;87(3):305. doi: 10.1002/ajh.22125. Epub 2011 Aug 4. No abstract available.

5.

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, Lacombe F, Lemez P, Marinov I, Matutes E, Maynadié M, Oelschlagel U, Orfao A, Schabath R, Solenthaler M, Tschurtschenthaler G, Vladareanu AM, Zini G, Faure GC, Porwit A.

Leukemia. 2011 Apr;25(4):567-74. doi: 10.1038/leu.2010.312. Epub 2011 Jan 21. Review.

PMID:
21252983
6.

Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02).

Leupin N, Schuller JC, Solenthaler M, Heim D, Rovo A, Beretta K, Gregor M, Bargetzi MJ, Brauchli P, Himmelmann A, Hanselmann S, Zenhäusern R.

Leuk Lymphoma. 2010 Apr;51(4):613-9. doi: 10.3109/10428191003624231.

PMID:
20218808
7.

Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).

Zenhäusern R, Schmitz SF, Solenthaler M, Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A.

Leuk Lymphoma. 2009 Sep;50(9):1501-11. doi: 10.1080/10428190903131755.

PMID:
19672771
8.

Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression.

Mumprecht S, Schürch C, Schwaller J, Solenthaler M, Ochsenbein AF.

Blood. 2009 Aug 20;114(8):1528-36. doi: 10.1182/blood-2008-09-179697. Epub 2009 May 6.

9.

Bulky extramedullary hematopoiesis is not a rare complication of congenital dyserythropoietic anemia.

Heimpel H, Dührsen U, Hofbauer P, Rigamonti-Wermlinger V, Kreuser ED, Schwarz K, Solenthaler M, Pauls S.

Ann Hematol. 2009 Oct;88(10):937-41. doi: 10.1007/s00277-009-0735-5. Epub 2009 Mar 31.

PMID:
19333601
10.

Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia: a multicentre trial SAKK 32/95.

Zenhäusern R, Von Rohr A, Rufibach K, Solenthaler M, Meyer-Monard S, Gratwohl A, Hess U, Bargetzi MJ, Kovacsovic T, Leoncini L, Tobler A; Swiss Group for Clinical Cancer Research (SAKK).

Leuk Lymphoma. 2009 Jan;50(1):133-6. doi: 10.1080/10428190802527681. No abstract available.

PMID:
19152171
11.

[Pancytopenia and hemolysis--diagnosis, differential diagnosis and therapy of pernicious anemia].

Meier N, Lipp E, Solenthaler M.

Dtsch Med Wochenschr. 2007 Jul 29;132(27):1469-74. Review. German.

PMID:
17583831
12.

Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.

Hehlmann R, Berger U, Pfirrmann M, Heimpel H, Hochhaus A, Hasford J, Kolb HJ, Lahaye T, Maywald O, Reiter A, Hossfeld DK, Huber C, Löffler H, Pralle H, Queisser W, Tobler A, Nerl C, Solenthaler M, Goebeler ME, Griesshammer M, Fischer T, Kremers S, Eimermacher H, Pfreundschuh M, Hirschmann WD, Lechner K, Wassmann B, Falge C, Kirchner HH, Gratwohl A.

Blood. 2007 Jun 1;109(11):4686-92. Epub 2007 Feb 22.

13.

Pleural tumors as sole primary manifestation of acute promyelocytic leukemia.

Mueller BU, Buerger AU, Solenthaler M, Garamvoelgyi EM, Oppliger-Leibundgut E, Fey MF, Pabst T.

Ann Oncol. 2006 Apr;17(4):722-3. Epub 2005 Nov 15. No abstract available.

14.

Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.

Beyer V, Mühlematter D, Parlier V, Cabrol C, Bougeon-Mamin S, Solenthaler M, Tobler A, Pugin P, Gregor M, Hitz F, Hess U, Chapuis B, Laurencet F, Schanz U, Schmidt PM, van Melle G, Jotterand M.

Cancer Genet Cytogenet. 2005 Jul 15;160(2):97-119. Review.

PMID:
15993266
15.

Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.

Clin Cancer Res. 2005 Feb 15;11(4):1416-24. Erratum in: Clin Cancer Res. 2005 Aug 1;11(15):5659.

16.

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura.

Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, Solenthaler M, Alberio L, Zwicky C, Fontana S, Taleghani BM, Tobler A, Lämmle B.

Haematologica. 2004 Mar;89(3):320-4.

17.

[Chronic myeloid leukemia--update].

Tobler A, Solenthaler M.

Ther Umsch. 2004 Feb;61(2):143-50. German.

PMID:
15018397
18.

[Myelodysplastic syndromes--an overview for the practitioner].

Solenthaler M, Tobler A.

Ther Umsch. 2004 Feb;61(2):117-24. German.

PMID:
15018394
19.

Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H).

Gautschi O, Blumenthal N, Streit M, Solenthaler M, Hunziker T, Zenhäusern R.

Eur J Haematol. 2004 Jan;72(1):61-3.

PMID:
14962265
20.

Congenital dyserythropoietic anaemia type II (HEMPAS) and haemochromatosis: a report of two cases.

Kremer Hovinga JA, Solenthaler M, Dufour JF.

Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1141-7.

PMID:
14501626
21.

p53 and mdm2 in mantle cell lymphoma in leukemic phase.

Solenthaler M, Matutes E, Brito-Babapulle V, Morilla R, Catovsky D.

Haematologica. 2002 Nov;87(11):1141-50.

22.

Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.

Calderoni A, von Briel C, Aebi S, Solenthaler M, Betticher DC.

Lung Cancer. 2002 Jun;36(3):321-6.

PMID:
12009245
23.

Should whole-body red cell mass be measured or calculated?

Balga I, Solenthaler M, Furlan M.

Blood Cells Mol Dis. 2000 Feb;26(1):25-31; discussion 32-6.

PMID:
10772873
24.

Severe inclusion body beta-thalassaemia with haemolysis in a patient double heterozygous for beta(0)-thalassaemia and quadruplicated alpha-globin gene arrangement of the anti-4.2 type.

Beris P, Solenthaler M, Deutsch S, Darbellay R, Tobler A, Bochaton-Pialat ML, Gabbiani G.

Br J Haematol. 1999 Jun;105(4):1074-80.

PMID:
10554822
25.

A novel BCR-ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph-chromosome and monosomy 7.

Leibundgut EO, Jotterand M, Rigamonti V, Parlier V, Mühlematter D, Tobler A, Solenthaler M.

Br J Haematol. 1999 Sep;106(4):1041-4.

PMID:
10520010
27.

[Deep venous thrombosis of the leg in acquired thrombophilia--hyperhomocysteinemia as a sequela of undetected celiac disease].

Kremer Hovinga JA, Baerlocher G, Wuillemin WA, Solenthaler M.

Ther Umsch. 1999 Sep;56(9):519-22. German.

PMID:
10517124
28.

[Isolated increased aPTT with anamnestic hemorrhagic diathesis--severe FXI deficiency].

Redondo M, Solenthaler M, Zeerleder S, Wuillemin WA.

Ther Umsch. 1999 Sep;56(9):502-4. German.

PMID:
10517119
29.

[Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].

Wuillemin WA, Solenthaler M.

Vasa. 1999 Aug;28(3):151-5. Review. German.

PMID:
10483317
30.

Fatal fresh frozen plasma infusion containing HPA-1a alloantibodies.

Solenthaler M, Krauss JK, Boehlen F, Koller R, Hug M, Lämmle B.

Br J Haematol. 1999 Jul;106(1):258-9. No abstract available.

PMID:
10444202
31.

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lämmle B.

N Engl J Med. 1998 Nov 26;339(22):1578-84.

32.
33.

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.

Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B.

Blood. 1997 May 1;89(9):3097-103.

34.

Venous thrombosis after caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency.

Biasiutti FD, Stucki B, Solenthaler M, Tobler A, Furlan M, Lämmle B.

Eur J Haematol. 1997 Feb;58(2):127-9. No abstract available.

PMID:
9111596
35.

Arrhythmogenic right ventricular dysplasia in identical twins.

Solenthaler M, Ritter M, Candinas R, Jenni R, Amann FW.

Am J Cardiol. 1994 Aug 1;74(3):303-4. No abstract available.

PMID:
8037147
36.

[Right ventricular dysplasia (right ventricular cardiomyopathy). Clinical aspects, diagnosis and course in 15 patients from the Zurich area].

Solenthaler M, Ritter M, Candinas R, Jenni R, Schneider J, Amann FW.

Schweiz Med Wochenschr. 1993 Aug 28;123(34):1604-14. Review. German. Erratum in: Schweiz Med Wochenschr 1993 Oct 9;123(40):1926.

PMID:
8378761

Supplemental Content

Loading ...
Support Center